← All trials
NCT05757570
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 3, 2023
- Primary completion
- Nov 30, 2027
- Completion date
- Nov 30, 2027
- First posted
- Mar 7, 2023
- Last posted
- Dec 18, 2023
- Enrollment
- 126
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Alpine Immune SciencesLead sponsor
- Alpine Immune SciencesStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.